Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-methyl-3-([4-(2-thienylmethyl)phenyl]amino)quinoxalin-2(1H)-one | 50% inhibition at 0.00011 mM in glycogenolysis assay, no bioavailability in vivo | Rattus norvegicus | |
3-[(4-isoxazolidin-3-ylphenyl)amino]-1-methylquinoxalin-2(1H)-one | 50% inhibition at 0.00011 mM in glycogenolysis assay, no bioavailability in vivo | Rattus norvegicus | |
4-[(4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)amino]-N-(2-thienylmethyl)benzamide | 50% inhibition at 0.00014 mM in glycogenolysis assay, no bioavailability in vivo | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hepatocyte | - |
Rattus norvegicus | - |